AI & Technology

DUPHAT 2026 to Convene Over 1,100 Global Brands in Dubai as Emirates Drug Establishment Backs AI-Driven Healthcare Ecosystem

Gathering 25,000 specialists from 85 countries at the Dubai World Trade Centre, the 31st edition showcases AI drug discovery, automated supply chains, and advanced local pharmaceutical manufacturing.

By 19Network Editorial Team · Aug 20, 2026 · 5 min read

A wide view of a modern pharmaceutical exhibition hall in Dubai where professionals network among rows of branded booths. | credit:Ai generated image

Over 1,100 pharmaceutical and technology brands gather in Dubai for DUPHAT 2026, officially backed by the Emirates Drug Establishment to advance AI-driven medicine and supply chain resilience.

Key Takeaways

Global Scale and Footprint: The 31st edition of the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT 2026) convenes more than 1,100 brands and over 25,000 visitors across 85 countries at the Dubai World Trade Centre.
Emirates Drug Establishment Support: Backed by official support from the Emirates Drug Establishment (EDE) to enhance regulatory frameworks, local manufacturing capacity, and supply chain security.
Artificial Intelligence Integration: Focuses heavily on AI applications in drug discovery, algorithmic clinical trials, ethical pharmacovigilance, and automated biopharmaceutical logistics.
Extensive Scientific Program: Features 104 specialized scientific sessions, 12 practical workshops, and 400 research poster presentations evaluated by global academic bodies.
National Strategy Alignment: Accelerates the UAE National Healthcare Strategy and Dubai Economic Agenda (D33) by positioning the country as a primary regional and global biopharma manufacturing hub.

The 31st edition of the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT 2026) is set to convene next Tuesday at the Dubai World Trade Centre (DWTC), establishing an international nexus for artificial intelligence innovation, clinical pharmacology, and advanced biomanufacturing. Gathering more than 1,100 participating global brands and welcoming upwards of 25,000 specialists, researchers, and trade visitors from 85 countries, the three-day exhibition reinforces Dubai's position as a premier launchpad for medical and pharmaceutical technologies across the Middle East, Africa, and South Asia. A defining milestone for this year's edition is the official institutional backing provided by the Emirates Drug Establishment (EDE). As the UAE’s apex federal authority overseeing national pharmaceuticals, medical devices, and biosecurity, the EDE’s formal integration into DUPHAT 2026 is designed to strengthen public-private collaboration, modernize regulatory pathways, accelerate domestic pharmaceutical production, and safeguard cross-border supply chain resilience in alignment with the UAE National Healthcare Strategy. The 2026 summit arrives at a transformative juncture as generative and predictive artificial intelligence reshape the global life sciences sector. Rather than focusing solely on traditional wholesale distribution, DUPHAT 2026 dedicates substantial platform space to computational drug discovery, robotic laboratory automation, and…

Read on 19Network